Celldex Therapeutics, Inc. ( CLDX) - Key Metrics
CLDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0 | -$1.22 | -$0.96 | -$0.98 |
| 2025Q3 | ? | -$1.01 | -$0.73 | -$0.74 |
| 2025Q2 | $0.01 | -$0.85 | -$0.66 | -$0.67 |
| 2025Q1 | $0.01 | -$0.81 | -$0.82 | -$0.82 |
| 2024Q4 | $0.02 | -$0.71 | -$0.49 | -$0.50 |
CLDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -5.55 |
| 2025Q3 | ? | -6.41 |
| 2025Q2 | ? | -5.97 |
| 2025Q1 | ? | -5.60 |
| 2024Q4 | ? | -8.90 |
CLDX
Price: $32.12
52 week price:
Earnings Per Share: -3.90 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 345800
Ebitda: -30.7 millionMarket Capitalization: 2.0 billion